Yong Yu, VP, Clinical Trial Operations at GENELUX Corp (GNLX), sold 20,800 shares at $22.29 ($455K) on 2023-09-15, disclosed to the SEC on 2023-09-18.
Open-market sale of $455k GNLX by VP, Clinical Trial Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.56 | 5,725 | $123K | 27.1% |
| 2 | $21.56 | 5,725 | $123K | 27.1% |
| 3 | $22.29 | 4,675 | $104K | 22.9% |
| 4 | $22.29 | 4,675 | $104K | 22.9% |
| Total | $21.89 avg | 20,800 | $455K | 100% |
| Filing → |
| GNLX | SELL | 2026-05-12 | $2K | — | Filing → |
| GNLX | SELL | 2026-03-26 | $2K | — | Filing → |
| GNLX | SELL | 2025-12-11 | $16K | — | Filing → |